Vermillion & White Wealth Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24	Closed	-$3.16K	–	602
2025 Q3	$3.16K	Hold	24	–	–	﹤0.01%	475
2025 Q2	$2.55K	Hold	24	–	–	﹤0.01%	446
2025 Q1	$2.98K	Hold	24	–	–	﹤0.01%	431
2024 Q4	$2.96K	Buy	+24	New	+$2.83K	﹤0.01%	309
2024 Q1	–	Sell	-24	Closed	-$2.95K	–	357
2023 Q4	$2.95K	Buy	+24	New	+$3K	﹤0.01%	235

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vermillion & White Wealth Management Group's JAZZ Position: Q4 2025 in Review

Vermillion & White Wealth Management Group sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 24 shares — an estimated $3.16K sold.

Vermillion & White Wealth Management Group first reported a position in JAZZ in Q4 2023 and held it in 5 quarters. The position peaked at $3.16K in Q3 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

Vermillion & White Wealth Management Group reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 24 Jazz Pharmaceuticals shares in Q4 2025, an estimated $3.16K.
Vermillion & White Wealth Management Group first reported a position in Jazz Pharmaceuticals in Q4 2023 and held it in 5 quarters.
Vermillion & White Wealth Management Group's Jazz Pharmaceuticals position peaked at $3.16K in Q3 2025.
573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2025, filed 18 Feb 2026.